$1.380
+0.143 (+10.39%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Chemomab Therapeutics Ltd (CMMB) Moving Averages Convergence Divergence (MACD) indicator is -0.12, suggesting CMMB is Sell.
Chemomab Therapeutics Ltd (CMMB) 20-Day simple moving average is 1.18, while Chemomab Therapeutics Ltd (CMMB) share price is $—, making it Buy.
Chemomab Therapeutics Ltd (CMMB) 60-Day simple moving average is 1.85, while Chemomab Therapeutics Ltd (CMMB) share price is $—, making it Sell.
Technical Analysis for CMMB
AI Technical CMMBAs of 2026-11-07, the technical board for Chemomab Therapeutics Ltd (CMMB) reads sell: 4 indicators are flashing buy, 5 are indicating sell, and 4 are neutral. Price at $1.38 sits below the 60-day and 200-day moving averages and above the 5-day, 10-day and 20-day.
Momentum readings: RSI stands at 48.783, MACD stands at -0.12 (Sell), Stochastic %K stands at 79.847, Stochastic %D stands at 71.498 and CCI stands at 94.301.
CMMB trades below the 60-day SMA (1.85) and below the 200-day SMA (1.74). Immediate resistance sits at Classic R1 1.38, then R2 1.61. Support sits at Classic S1 0.92, then S2 0.69.
Chemomab Therapeutics Ltd (CMMB) Support & Resistance Level
Chemomab Therapeutics Ltd (CMMB) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 48.783 |
| STOCHk_14_3_3 | 79.847 |
| STOCHd_14_3_3 | 71.498 |
| CCI_20 | 94.301 |
| AO_5_34 | -0.170 |
| MOM_10 | 0.290 |
| MACD_12_26_9 | -0.120 |
Chemomab Therapeutics Ltd (CMMB) Relative Strength Index (RSI_14) is 48.783, creating a Neutral signal.
Chemomab Therapeutics Ltd (CMMB) Stochastic %K is 79.847, creating a Neutral signal.
Chemomab Therapeutics Ltd (CMMB) Stochastic %D is 71.498, creating a Neutral signal.
Chemomab Therapeutics Ltd (CMMB) CCI_20 is 94.301, creating a Neutral signal.
Chemomab Therapeutics Ltd (CMMB) Awesome Oscillator (AO) is -0.170, creating a Sell signal.
Chemomab Therapeutics Ltd (CMMB) Momentum (MOM) is 0.290, creating a Buy signal.
Chemomab Therapeutics Ltd (CMMB) Moving Average Convergence Divergence (MACD) is -0.120, creating a Sell signal.
Chemomab Therapeutics Ltd (CMMB) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.232 | Buy |
| MA_10 | 1.156 | Buy |
| MA_20 | 1.182 | Buy |
| MA_60 | 1.852 | Sell |
| MA_200 | 1.743 | Sell |
| MA_250 | 1.828 | Sell |
Chemomab Therapeutics Ltd (CMMB) 5-Day simple moving average is 1.232, while Chemomab Therapeutics Ltd (CMMB) share price is $, making it a Buy.
Chemomab Therapeutics Ltd (CMMB) 10-Day simple moving average is 1.156, while Chemomab Therapeutics Ltd (CMMB) share price is $, making it a Buy.
Chemomab Therapeutics Ltd (CMMB) 20-Day simple moving average is 1.182, while Chemomab Therapeutics Ltd (CMMB) share price is $, making it a Buy.
Chemomab Therapeutics Ltd (CMMB) 60-Day simple moving average is 1.852, while Chemomab Therapeutics Ltd (CMMB) share price is $, making it a Sell.
Chemomab Therapeutics Ltd (CMMB) 200-Day simple moving average is 1.743, while Chemomab Therapeutics Ltd (CMMB) share price is $, making it a Sell.
Chemomab Therapeutics Ltd (CMMB) 250-Day simple moving average is 1.828, while Chemomab Therapeutics Ltd (CMMB) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.